Superoxide Dismutase and Reduced Bronchopulmonary Dysplasia

• Superoxide dismutase for bronchopulmonary dysplasia in preterm infants.

  • 2023-10-09
  • Systematic Review · n = 380
  • The Cochrane database of systematic reviews 2023(10)
  • • Martina Albertella
    • Rahul R Gentyala
    • Themistoklis Paraskevas
    • Danielle Ehret
    • Matteo Bruschettini
    • Roger Soll

  • PubMed: 37811631
  • DOI: 10.1002/14651858.cd013232.pub2

  4 Insights on

  • Reduced Bronchopulmonary Dysplasia

  • High evidence
  • Clinical

  The evidence is very uncertain about the effect of SOD on BPD defined as an oxygen requirement at 28 days (RR 1.09, 95% CI 0.94 to 1.26; RD 0.06, 95% CI -0.05 to 0.16, 1 study, 302 infants)

  Effect

  Neutral

  Effect size

  Small

  Significant

  No